共 18 条
[1]
Physiology and pathology of tau protein kinases in relation to Alzheimer Disease. Imabori K, Uchida T. Journal of Biolchemistics . 1997
[2]
Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk-5) in developing cerebellar macroneurons. Pigino G, Pagline G, Ulloa l, et al. Journal of Cell Science . 1997
[3]
Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation. Sharma P, Sharma M, Amin N, et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[4]
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. G I Kusakawa, T saito, R Onuki, et al. Journal of Biological Chemistry . 2000
[5]
Protein sequence and mass spectrometric analyses of Tau in Alzheimer disease brain. Hasegawa M, Morishima K M, Takio K, et al. Journal of Biological Chemistry . 1993
[6]
cdk-5 is Involved in Neuregulin-Induced AchR Expression at the Neuromuscular Junction. Fu A K, Fu W Y, Cheung J, et al. Nature Neuroscience . 2001
[7]
P35 is a neuralspecific regulatory subunit of cyclin-dependent kinase 5. Tsai L H, Dellale I, Caviness V, et al. Nature . 1994
[8]
The cdk-5/ p35 Kinase is Essential for Neurite Outgrowth during Neuronal Differentiation. Nikolic M, Dudek H, Kwon Y T, et al. Genes and Development . 1996
[9]
Tau protein kinase I convaents normal tau protein into A8-like component of paired helical filaments. Ishiguro K, Takamatsu M, Tomizawa K, et al. Journal of Biological Chemistry . 1992
[10]
Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase inhibits Tau’s ability to promote microtubule assembly. Evans D B, Rank K B, Bhattacharya K, et al. Journal of Biological Chemistry . 2000